BHM4278

N/A

Report date: 2024/12/03 16:45:14
NME

Base Information

Drug NameBHM4278
Drug Alias NameBHM4278BHM-4278
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHedgehog cell-signalling pathway inhibitors
TargetsUpdating
Therapy Area/IndicationsPancreatic NeoplasmsBasal Cell Nevus Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Hanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Hanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsBasal Cell Nevus Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A